Here Is What PMOS Means for You
PCOS New Name 2026 | What Is PMOS | Symptoms, Diagnosis, Treatment & the Lancet Study Explained
After 90 Years, the Name Finally Changed
Suppose for years you are told you have cysts on your ovaries and you find out that most women with the same diagnosis don’t have cysts. This is the condition millions of women have had to deal with since 1935, when the term ‘polycystic ovary syndrome’ was first mentioned in medical textbooks.
That changed today.
A revolutionary paper on the 12th of May 2026 in The Lancet officially changed the name of polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS). The switch came after 11 years of research, and after over 22,000 patient and health care professional contributions to a survey, and the consensus of over 50 leading global medical organisations, including the Endocrine Society.
This isn’t an ordinary management announcement. It is a basic rethinking of a disease of 1 in 8 women – 170 million people all over the world. For many of those women, it’s when medicine finally caught up with what they’ve been feeling from the get-go.
BREAKING — The Lancet, May 12, 2026
PCOS has been officially renamed PMOS (polyendocrine metabolic ovarian syndrome) in a landmark Lancet paper published today. The change follows 11 years of research, 22,000+ survey responses, and input from 50+ global organisations. A 3-year transition period begins now.
Table of Contents
What Changed — PCOS to PMOS
It’s a trivial change on the surface; one letter, M replaced by C. However, the distinction between polyCYSTIC and polyENDOCRINE METABOLIC is a complete change of mindset in the medical world.
| Old Name: PCOS | New Name: PMOS | |
| Full name | Polycystic Ovary Syndrome | Polyendocrine Metabolic Ovarian Syndrome |
| Focus | Ovarian cysts (often absent) | Endocrine + metabolic systems (always present) |
| Implies | Primarily a gynaecological problem | A whole-body hormonal and metabolic condition |
| Problem | Many patients have no cysts at all | Accurately reflects the real biology |
| Care team | Mainly gynaecologists | Endocrinologists, GPs, mental health, cardiology |
| Published | 1935 | May 12, 2026 — The Lancet |
The term ‘polycystic’ was always a problem. What it calls ‘cysts’ are not cysts, but rather small, underdeveloped follicles. The research paper, which appeared along with the name change, uncovered something remarkable: There is no increase in abnormal ovarian cysts among women with this condition. The name was referring to something that doesn’t exist, and neglecting everything else.
A Real-World Example — Why This Matters
Imagine Sarah, a 26-year-old teacher in the UK city of Manchester. She visited her GP with irregular periods, acne around her jawline and weight gain around her stomach that she had been careful about her diet. Her GP ordered a scan of her abdomen. Report was returned: No polycystic ovary can be seen. No significant cysts. Your GP said to her: ‘Your ovaries are fine’. It is unlikely to be PCOS’
Sarah was sent home without a diagnosis. For the next three years she progressively declined, developing prediabetes, aggravating acne and severe anxiety. When she finally consulted her endocrinologist on her own, the whole picture became clear – elevated androgens, insulin resistance, imbalanced LH:FSH ratio and elevated AMH. Classic PMOS. She didn’t have the follicular finding and the scan had been interpreted as normal, but the hormones and the metabolism were easily identifiable.
Sarah’s story wasn’t unusual. Even up to 70% of women with PCOS may not be diagnosed. Doctors ruled out the diagnosis when there were no cysts (as they did with her) and the truth of the matter was not known and treated.
With the new PMOS, Sarah would be instantly identifiable. The endocrine and metabolic characteristics are what help define the condition, and not the appearance on an ultrasound.
What Is PMOS? The Condition Properly Explained
PMOS is a long-term, complex endocrine and metabolic disorder of the way hormones function in the body. It is defined by three key characteristics (and at least two are necessary for diagnosis):
- Ovulatory dysfunction — irregular, fewer or no periods due to the disruption of the growth of the follicles.
- Hyperandrogenism — high levels of male hormones (androgens) which may lead to acne, excess body hair (hirsutism) or thinning hair on the top of the scalp
- Arrested follicle development with polycystic ovarian morphology seen on ultrasound or elevated anti-Müllerian hormone (AMH)
All of these features are caused by insulin signalling abnormalities, androgen excess and disrupted neuroendocrine function. PMOS is not a disease of the ovaries with metabolic consequences, but a metabolic and endocrine disease, with consequences that extend far beyond the reproductive system.
Every System PMOS Can Affect
- Reproductive system — irregular periods, ovulation problems, difficulty conceiving, increased risk of miscarriage
- Metabolic health — insulin resistance, weight gain (especially in abdomen), increased risk of diabetes (Type 2); PMOS female patients are 4x more likely to develop Type 2 diabetes
- Cardiovascular system — raised blood pressure, dyslipidaemia (high triglycerides, low HDL), raised longer-term risk of heart disease
- Skin and hair — acne, hirsutism, male-pattern hair thinning, acanthosis nigricans (dark skin patches caused by insulin resistance)
- Mental health — very high prevalence of depression, anxiety and disordered eating; frequently overlooked and under-addressed
- Sleep — increased incidence of OSA, especially in women with insulin resistance
How the Renaming Happened — 11 Years, 22,000 Voices
The name change campaign was spearheaded by Dr Helena Teede, an endocrinologist at Monash University in Australia, who has spent decades studying the condition and personally experienced the harm that has been done to patients due to the inaccuracy of its name. It was as simple as that, she said: ‘The name is not accurate.’
The ensuing process was unprecedented in size. It collected over 22,000 responses in a survey from patients and multidisciplinary health professionals from all over the world for more than 11 years. Consensus-building was achieved through iterative global surveys, modified Delphi methods and nominal group workshops.
Over 50 academic, clinical and patient organisations were involved, such as the Endocrine Society, Androgen Excess and PCOS Society, Verity (UK’s leading patient charity for PCOS) and the Royal Australian and New Zealand College of Obstetricians and Gynaecologists.
The vote was unanimous except for two workshop members who voted against the new name. The paper was published on International Nurses Day, 12th May 2026, simultaneously and published in both the Lancet and presented at the European Congress of Endocrinology that day.
The 3-Year Transition
The name will not change overnight in every doctor’s surgery. A 3-year transition period is now underway, during which clinical guidelines, medical education, and international disease classification systems (ICD codes) will be updated to reflect PMOS. During this period, both ‘PCOS’ and ‘PMOS’ will be in use — they refer to exactly the same condition.
What This Means If You Have PCOS — Practical Guide
The most important thing to understand is, if you have been diagnosed with PCOS, nothing about your condition has changed overnight and neither has your treatment. The symptoms are the same. The treatments are the same. Your medical record is still in effect. This is a renaming and not redefinition.
What is changing over time – the coming years – is the way the medical system treats the condition. What you can expect:
- Your doctor may keep using ‘PCOS’ for a while — this is normal and to be expected in the Transition period
- If you heard from your doctor that ‘you don’t have PCOS because your ultrasound was OK,’ re-evaluate with your doctor using all the diagnostic criteria — ovulatory dysfunction, hyperandrogenism, AND AMH/ultrasound. For each criterion, there was never a single diagnosis.
- Even though gynaecologists will be predominant in managing PMOS, expect more involvement from endocrinologists and metabolic specialists in managing PMOS.
- Support for mental health issues should be an integral part of the PMOS — push for it if it isn’t provided
- Cardiovascular and metabolic monitoring (blood pressure, HbA1c, cholesterol) should be provided regularly (if not, request it).
PMOS Treatment — What Actually Works
Lifestyle First
Lifestyle modification is the most evidence based treatment for PMOS. Great body weight loss of 5% in overweight women with PMOS can have a positive effect on hormonal markers, restore ovulation and lessen insulin resistance. Exercise, both aerobic and resistance, have a strong effect on insulin sensitivity, regardless of weight loss — that is, exercise helps the PMOS, even if the scales don’t go down.
The heart of PMOS is the insulin signalling abnormalities that can be directly counteracted by a low glycaemic index (low-GI) diet, which avoids sharp rises in blood sugar. There is growing evidence that an anti-inflammatory eating pattern (high in vegetables, oily fish, legumes and whole grain) is increasingly beneficial.
Medication
- Combined oral contraceptive pill — controls periods, reduces androgens and treats acne and hirsutism
- Metformin — enhances insulin sensitivity; now generally accepted as first line therapy for PMOS (with or without diabetes)
- Anti-androgens (spironolactone, cyproterone acetate) — decrease acne and excess hair growth.
- Letrozole or clomifene — (for women attempting to get pregnant by ovulation induction)
- Supplementation with inositol has been shown to improve insulin signalling and ovarian function, and is increasingly gaining recognition.
Frequently Asked Questions
Q: Why was PCOS renamed to PMOS?
It was the old name which was incorrect. The term ‘Polycystic’ meant ovarian cysts, but not every woman with polycystic had any cysts. The name change was accompanied by a paper that found no increase in abnormal ovarian cysts in the condition, either. The “true physiology” is related to the endocrine and metabolic systems, which is what the new name ‘polyendocrine metabolic ovarian syndrome’ alludes to.
Q: Is PCOS and PMOS the same condition?
Yes, completely. PCOS is the same condition as PMOS — now called that to accurately describe its biology. There are no changes in any of the symptoms, diagnostic criteria or treatments. PMOS is given to women who have been diagnosed with PCOS. The name change doesn’t change anything scientifically, it’s just a correction.
Q: When did PCOS change to PMOS?
The change in the official name of the journal was published in The Lancet on 12 May 2026, and presented at the European Congress of Endocrinology in Prague on the same date. The change was based on an 11-year international consensus building process through which 22,000+ people from around the world responded and 50+ medical organisations contributed. International updates to clinical guidelines and disease classification schemes are now in progress and will take place over a 3 year period.
Q: How is PMOS diagnosed?
The diagnosis is made if there are at least 3 of the following: hyperandrogenism (increased androgens, which can lead to acne, hirsutism and/or hair loss) and/or polycystic ovarian morphology (ultrasound) and/or amh blood levels are elevated. Other causes need to be eliminated. Importantly, a clear ultrasound does not exclude PMOS, the endocrine/metabolic aspects are important.
Q: Does the name change affect my treatment?
Not immediately. There are no new treatments at this time. Reclassification of PMOS as a multisystem endocrine and metabolic condition on the other hand, should over time foster more comprehensive care, with better involvement of endocrinologists, cardiologists, mental health professionals, as well as gynaecologists. If you are diagnosed with PMOS, it is important to ask your doctor if your metabolic measures (such as insulin, HbA1c, cholesterol and blood pressure) are being monitored regularly.
Conclusion — A Name That Finally Tells the Truth
The renaming of PCOS to PMOS isn’t just semantics — for the women who spent years getting shrugs of dismissiveness and lack of concern from the medical community for ‘the scan looks fine’ when it really didn’t, for the patients who were told they had a cyst problem when they actually had a metabolic problem, for the millions who had to hear their condition from employers, insurers and family members — it’s personal. That is the recognition that’s late.
We don’t have any new information to change this condition. However, the lens it looks through has — and that will change, making diagnoses more accurate, and changing priorities in treatment and removing the stigma that a misleading name has imposed over more than 90 years.
Pass this article on to all women you know that suffer from PCOS. They now have a name that captures the essence of what they truly are facing – and a world medical community that has officially recognized the need to consider the whole picture seriously now.
Medical Disclaimer
This article is for informational purposes only. Always consult a qualified healthcare professional for diagnosis and treatment of PMOS/PCOS.